Clinical Trial Update: A Study of Milvexian in Participants After a Recent Acute Coronary Syndrome [Phase 3]

View source ↗

Summary

Phase 3 trial update of milvexian in participants after acute coronary syndrome has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Coronary Syndrome

Drugs mentioned

• Milvexian (milvexian)

Snippet

Sponsor: Janssen Research & Development, LLC | Conditions: Acute Coronary Syndrome | Phase 3 | Status: COMPLETED